Perennial Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Perennial Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray [Phase 3]
Phase 3 safety trial in children with seasonal and perennial allergic rhinitis evaluating GW685698X aqueous nasal spray versus placebo has c…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Seasonal Allergic Rhinitis In Pediatric Subjects [Phase 3]
Phase 3 pediatric trial update for seasonal and perennial allergic rhinitis sponsored by GlaxoSmithKline; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults [Phase 3]
Phase 3 study of GW685698X for perennial allergic rhinitis in adolescents and adults has completed.
-
FDA approval · 2016-08-19FDA Approved: FEXOFENADINE HCL — Original Application (Strategic Sourcing Services)
FDA approves the original application for fexofenadine hydrochloride, a generic antihistamine, submitted by Strategic Sourcing Services.
-
FDA approval · 2016-06-23FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Montelukast from BluePoint Laboratories.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-04-19FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Montelukast Sodium from Unichem Pharmaceuticals (USA), Inc., under the ANDA.
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis. [Phase 3]
Phase 3 clinical trial evaluating the effectiveness of two loratadine-pseudoephedrine preparations in patients with perennial allergic rhini…
-
FDA approval · 2016-03-17FDA Approved: OMNARIS — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Omnaris (ciclesonide) submitted by Covis Pharma US, Inc. The notice indicates the supplemental a…
-
FDA approval · 2016-01-26FDA Approved: FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for a fixed-dose combination of fexofenadine HCl and pseudoephedrine HCl to treat allergy symptoms w…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: A Study in Subjects With Perennial Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial in perennial allergic rhinitis conducted by Merck Sharp & Dohme has completed.
-
FDA approval · 2016-01-12FDA Approved: MONTELUKAST SODIUM — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals, LLC's original application for Montelukast SODIUM, establishing a generic montelukast sodium produ…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis [Phase 3]
A confirmatory Phase 3 study of TAU-284 in pediatric patients with perennial allergic rhinitis has completed and posted results. The study w…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis [Phase 3]
Tanabe's TAU-284 completed a long-term Phase 3 study in pediatric patients with perennial allergic rhinitis; results were posted in 2015.
-
FDA approval · 2015-11-25FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin-D 12 Hour, combining loratadine and pseudoephedrine sulfate. The approval expands the p…
-
FDA approval · 2015-10-16FDA Approved: CLARINEX-D 12 HOUR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for CLARINEX-D 12 HOUR, a desloratadine and pseudoephedrine sulfate combination, from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR) [Phase 3]
Phase 3 trial update on hypothalamic-pituitary-adrenal axis safety in pediatric perennial allergic rhinitis; the study is completed and resu…
-
FDA approval · 2015-10-01FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Marlex Pharmaceuticals Inc)
FDA approved a supplemental application for levocetirizine dihydrochloride from Marlex Pharmaceuticals Inc, indicating an approved regulator…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of eN-Lac® capsules (Lactobacillus paracasei GMNL-32) in children with perennial a…
-
FDA approval · 2015-07-31FDA Approved: MONTELUKAST SODIUM — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original application for montelukast sodium (generic montelukast), authorizing a generic product for t…
-
FDA approval · 2015-06-18FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Nasacort Allergy 24HR (triamcinolone acetonide) from Chattem, Inc.
-
FDA approval · 2015-05-22FDA Approved: MONTELUKAST SODIUM — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original generic application for montelukast sodium, enabling marketing of a generic montelukast pr…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) [Phase 4]
Phase 4 trial reports on the efficacy and safety of Loratadine-Betamethasone oral solution for severe perennial allergic rhinitis in childre…
-
FDA approval · 2015-04-16FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Allergy (loratadine) from Bayer HealthCare LLC.
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)
This clinical trial update describes observational usage of Loratadine (Claritin) in pediatric patients using tablet, RediTabs, and dry syru…
-
FDA label_change · 2014-11-26FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a labeling supplemental application for Singulair (montelukast) submitted by Organon LLC.